Extendicare (TSE:EXE) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened

Extendicare Inc. (TSE:EXEGet Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$10.12 and traded as high as C$13.35. Extendicare shares last traded at C$13.06, with a volume of 305,519 shares.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Royal Bank of Canada boosted their price target on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a report on Thursday, November 28th. BMO Capital Markets boosted their price target on Extendicare from C$11.00 to C$13.50 in a report on Monday, March 3rd. TD Securities boosted their price target on Extendicare from C$10.50 to C$13.00 and gave the stock a “hold” rating in a report on Monday, March 3rd. Finally, Cormark raised Extendicare to a “moderate buy” rating in a report on Wednesday, February 19th.

Read Our Latest Stock Analysis on EXE

Extendicare Stock Up 1.0 %

The firm has a market capitalization of C$1.09 billion, a PE ratio of 16.65 and a beta of 1.26. The company has a fifty day moving average price of C$11.19 and a 200-day moving average price of C$10.12. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62.

Extendicare Announces Dividend

The company also recently disclosed a monthly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 17th were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.48 annualized dividend and a dividend yield of 3.68%. Extendicare’s dividend payout ratio (DPR) is 61.20%.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Articles

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.